BG47497A3 - Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidineacetamide - Google Patents

Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidineacetamide

Info

Publication number: BG47497A3
Authority: BG; Bulgaria
Prior art keywords: oxo; alpha; ethyl; compound; hypoxia
Prior art date: 1984-05-15

Application number

BG070238A

Other languages

Bulgarian (bg)

English (en)

Inventor

Jean Gobert

Jean-Pierre Geerts

Guy Bodson

Original Assignee

Ucb S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-05-15

Filing date

1985-05-14

Publication date

1990-07-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10560974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG47497(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-05-14 Application filed by Ucb S.A. filed Critical Ucb S.A.

1990-07-16 Publication of BG47497A3 publication Critical patent/BG47497A3/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Detergent Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)
Seasonings (AREA)

BG070238A 1984-05-15 1985-05-14 Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidineacetamide BG47497A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB848412357A GB8412357D0 (en)	1984-05-15	1984-05-15	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
BG47497A3 true BG47497A3 (en)	1990-07-16

Family

ID=10560974

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BG089449A BG50156A3 (en)	1984-05-15	1985-05-04	Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidine- acetamide
BG070238A BG47497A3 (en)	1984-05-15	1985-05-14	Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidineacetamide

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BG089449A BG50156A3 (en)	1984-05-15	1985-05-04	Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidine- acetamide

Country Status (33)

Country	Link
US (3)	US4696943A (xx)
EP (1)	EP0162036B1 (xx)
JP (1)	JPH0629186B2 (xx)
KR (1)	KR920003819B1 (xx)
CN (1)	CN1015541B (xx)
AT (1)	ATE45567T1 (xx)
AU (1)	AU574465B2 (xx)
BG (2)	BG50156A3 (xx)
CA (1)	CA1235129A (xx)
CY (2)	CY1567A (xx)
DE (3)	DE10075021I1 (xx)
DK (1)	DK163501C (xx)
ES (2)	ES8608485A1 (xx)
FI (1)	FI80673C (xx)
GB (1)	GB8412357D0 (xx)
GE (1)	GEP20002001B (xx)
GR (1)	GR851155B (xx)
HK (1)	HK52391A (xx)
IE (1)	IE59950B1 (xx)
IL (1)	IL75179A (xx)
LT (1)	LT2584B (xx)
LU (2)	LU90615I2 (xx)
LV (1)	LV5233A3 (xx)
MY (2)	MY101725A (xx)
NL (1)	NL300028I2 (xx)
NO (2)	NO164534C (xx)
PL (2)	PL147386B1 (xx)
PT (1)	PT80460B (xx)
SA (1)	SA01210656A (xx)
SG (1)	SG80090G (xx)
SU (3)	SU1402260A3 (xx)
UA (1)	UA6158A1 (xx)
ZA (1)	ZA853635B (xx)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8827389D0 (en) *	1988-11-23	1988-12-29	Ucb Sa	Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
IT1231477B (it) *	1989-07-12	1991-12-07	Sigma Tau Ind Farmaceuti	(pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
GB9319732D0 (en) *	1993-09-24	1993-11-10	Ucb Sa	Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
US6107492A (en) *	1998-05-08	2000-08-22	Ucb, S.A.	Process for the preparation of levetiracetam
US6124473A (en) *	1998-05-08	2000-09-26	Ucb, S.A.	Process for preparing (s)- and (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide
EA002380B1 (ru) *	1999-07-21	2002-04-25	Российский Государственный Педагогический Университет Им. А.И.Герцена	Антиишемическое средство
EA002379B1 (ru) *	1999-07-21	2002-04-25	Российский Государственный Педагогический Университет Им. А.И.Герцена	Средство, обладающее антиишемической, гипотензивной и антигипоксической активностью
YU37602A (sh) *	1999-12-01	2005-07-19	Ucb S.A.	Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
GB0004297D0 (en) *	2000-02-23	2000-04-12	Ucb Sa	2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) *	2000-09-29	2004-02-03	Eastman Chemical Company	Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
US7112612B2 (en)	2000-11-21	2006-09-26	Ucb S.A.	N-alkylated GABA compounds, processes for their preparation and their use as medicaments
JPWO2002053153A1 (ja) *	2000-12-28	2004-04-30	第一製薬株式会社	神経因性疼痛治療及び予防薬
WO2002067931A1 (en) *	2001-02-23	2002-09-06	Johns Hopkins University	Treatment of tics, tremors and related disorders
AU2002329233B2 (en) *	2001-08-10	2007-08-16	Ucb Pharma	Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
JP4351909B2 (ja) *	2001-10-08	2009-10-28	ユセベファルマソシエテアノニム	薬剤を調製するための、２−オキソ−１−ピロリジン誘導体の使用
RU2216322C1 (ru) *	2002-02-28	2003-11-20	Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации"	Средство, обладающее антиишемической, гипотензивной, противоаритмической и ноотропной активностью
AU2003242538A1 (en) *	2002-05-14	2003-11-11	Ucb, S.A.	Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
EP1517893A2 (en) *	2003-02-03	2005-03-30	Teva Pharmaceutical Industries Limited	Process for producing levetiracetam
ES2214147B1 (es) *	2003-02-28	2005-10-01	Farma-Lepori S.A.	Procedimiento de obtencion de un agente antiepileptico.
US20050143445A1 (en) *	2003-03-18	2005-06-30	Parthasaradhi Reddy B.	Novel crystalline forms of levetiracetam
EP1663968A1 (en) *	2003-09-05	2006-06-07	Ranbaxy Laboratories Limited	Process for the preparation of pure levetiracetam
JP4658937B2 (ja) *	2003-09-24	2011-03-23	ユセベファルマソシエテアノニム	２−オキソ−１−ピロリジン誘導体の製造方法
JP2007513105A (ja)	2003-12-02	2007-05-24	ユセベソシエテアノニム	イミダゾール誘導体、その製法及び使用
US7531673B2 (en)	2004-02-18	2009-05-12	Dr. Reddy's Laboratories Limited	Preparation of amino acid amides
CA2488325C (en) *	2004-11-22	2010-08-24	Apotex Pharmachem Inc.	Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
NZ556630A (en) *	2005-01-27	2010-12-24	Alembic Ltd	Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
WO2006088864A1 (en) *	2005-02-16	2006-08-24	Elan Pharma International Limited	Controlled release compositions comprising levetiracetam
US20070298098A1 (en) *	2005-02-16	2007-12-27	Elan Pharma International Limited	Controlled Release Compositions Comprising Levetiracetam
WO2006090265A2 (en) *	2005-02-28	2006-08-31	Ranbaxy Laboratories Limited	Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions
EP1863761A1 (en) *	2005-03-10	2007-12-12	Rubamin Limited	Process for preparing levetiracetam
AU2006228947A1 (en) *	2005-03-30	2006-10-05	Mylan Pharmaceuticals Ulc	Combined-step process for pharmaceutical compositions
EP1879861A2 (en) *	2005-04-01	2008-01-23	Rubamin Laboratories Limited	Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives
EP1912966A2 (en)	2005-06-01	2008-04-23	Ucb, S.A.	2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
SI1909764T1 (sl) *	2005-07-26	2015-01-30	Ucb Pharma, S.A.	Farmacevtski sestavki, ki obsegajo levetiracetam in postopek za njihovo pripravo
US8338621B2 (en)	2005-12-21	2012-12-25	Ucb S.A.	Process for the preparation of 2-oxo-1-pyrrolidine derivatives
DE602006003617D1 (de) *	2006-01-24	2008-12-24	Teva Pharma	Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung.
US20080014271A1 (en) *	2006-07-13	2008-01-17	Ucb, S.A.	Novel pharmaceutical compositions comprising levetiracetam
WO2008012268A1 (en) *	2006-07-25	2008-01-31	Zach System S.P.A.	Process for the preparation of levetiracetam
WO2008021666A2 (en) *	2006-08-18	2008-02-21	Morton Grove Pharmaceuticals, Inc.	Stable liquid levetiracetam compositions and methods
CN101130504B (zh) *	2006-08-25	2010-07-28	苏州雅本化学股份有限公司	经合成、拆分与消旋化制备手性药物左乙拉西坦中间体(s)-(+)-2-氨基丁酰胺盐酸盐的方法
EP1932922A1 (de) *	2006-12-13	2008-06-18	Desitin Arzneimittel GmbH	Schnelltest zum Nachweis von DNA-Sequenzen
WO2008077035A2 (en) *	2006-12-18	2008-06-26	Dr. Reddy's Laboratories Ltd.	Processes for the preparation of levetiracetam
CN101333180B (zh) *	2007-06-29	2011-05-18	浙江华海药业股份有限公司	一种制备左乙拉西坦中间体的方法
US20090082422A1 (en) *	2007-09-26	2009-03-26	Protia, Llc	Deuterium-enriched levetiracetam
WO2009050735A1 (en) *	2007-10-15	2009-04-23	Lupin Limited	A novel polymorph of levetiracetam and a process for its preparation
US20090263481A1 (en) *	2008-04-17	2009-10-22	Atul Vishvanath Patil	Levetiracetam formulations
US20100003322A1 (en) *	2008-07-03	2010-01-07	Lai Felix S	Enteric coated hydrophobic matrix formulation
EP2147911A1 (en)	2008-07-24	2010-01-27	ZaCh System S.p.A.	Process for the preparation of levetiracetam
US20100190752A1 (en)	2008-09-05	2010-07-29	Gruenenthal Gmbh	Pharmaceutical Combination
ES2865504T3 (es) *	2008-10-16	2021-10-15	Univ Johns Hopkins	Procedimientos y composiciones para la mejora de la función cognitiva
EP2179725A1 (en)	2008-10-23	2010-04-28	LEK Pharmaceuticals D.D.	Pharmaceutical composition comprising levetiracetam
US8722715B2 (en) *	2008-11-07	2014-05-13	NovaBay Pharmaceuticals	Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
US20100159009A1 (en) *	2008-12-24	2010-06-24	Zhongshui Yu	Controlled-release formulations
US20100172979A1 (en) *	2008-12-24	2010-07-08	Zhongshui Yu	Controlled-release formulations
US8785661B2 (en)	2009-05-13	2014-07-22	Nektar Therapeutics	Oligome-containing pyrrolidine compounds
CN101885696A (zh) *	2009-05-14	2010-11-17	上海华理生物医药有限公司	一种合成高纯度左乙拉西坦的方法
EP2461808A2 (en)	2009-08-07	2012-06-13	UCB Pharma S.A.	Methods for enhancing the cognitive function
EP2298290A1 (en)	2009-09-16	2011-03-23	LEK Pharmaceuticals d.d.	Controlled release composition comprising levetiracetam
US7939676B2 (en) *	2009-09-17	2011-05-10	Zach System S.P.A.	Process for the preparation of levetiracetam
HUE028668T2 (en)	2009-10-23	2016-12-28	Ucb Biopharma Sprl	2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
EA037187B1 (ru) *	2010-02-09	2021-02-17	Дзе Джонс Хопкинс Юниверсити	Способ и композиция для лечения когнитивного расстройства
CN102884179A (zh)	2010-02-26	2013-01-16	加利福尼亚大学董事会	用于制备l-高丙氨酸的组合物和方法
EP2563340A2 (en)	2010-04-26	2013-03-06	Mahmut Bilgic	Water soluble pharmaceutical composition
US9333175B2 (en)	2010-06-16	2016-05-10	Mylan Inc.	Controlled release levetiracetam formulations and methods for producing the same
EP2492354A1 (en)	2011-02-23	2012-08-29	Institut National De La Recherche Agronomique (INRA)	Method for identifying compounds useful in the treatment of photosensitive reflex epilepsy
DK2699581T3 (en)	2011-04-18	2016-01-11	Ucb Biopharma Sprl	2-oxo-1-IMIDAZOLIDINYLIMIDAZOTHIADIAZOLDERIVATIVER
EP2524910A1 (en)	2011-05-17	2012-11-21	DSM IP Assets B.V.	Process for the resolution of aminobutyramide
CN102382027B (zh) *	2011-09-20	2013-11-13	浙江江北药业有限公司	一种左乙拉西坦的制备方法
CN102617436B (zh) *	2012-03-20	2014-02-12	浙江洪波化工有限公司	2-(2-氧代吡咯烷基）丁酰胺的制备方法
CN102633675A (zh) *	2012-04-10	2012-08-15	南京大学	一种dl-2-氨基丁酰胺制备方法
CN102675181B (zh) *	2012-06-07	2013-11-20	北京师宏药物研制中心	一种左乙拉西坦的制备方法
CN102702063B (zh) *	2012-06-15	2013-09-04	孙威	一种左乙拉西坦制备方法
WO2014012563A1 (en)	2012-07-20	2014-01-23	Ucb Pharma, S.A.	Compounds for enhancing the cognitive function
US10154988B2 (en)	2012-11-14	2018-12-18	The Johns Hopkins University	Methods and compositions for treating schizophrenia
CN103012190B (zh) *	2012-12-05	2015-03-18	江苏拜克新材料有限公司	一种s-2-氨基丁酰胺盐酸盐的合成方法
US10806717B2 (en)	2013-03-15	2020-10-20	The Johns Hopkins University	Methods and compositions for improving cognitive function
US9339489B2 (en)	2013-03-15	2016-05-17	Aprecia Pharmaceuticals Company	Rapid disperse dosage form containing levetiracetam
HK1216513A1 (zh)	2013-03-15	2016-11-18	阿普雷奇亚制药有限责任公司	包含左乙拉西坦的快速分散劑型
JP6433482B2 (ja)	2013-03-15	2018-12-05	エージンバイオ，インコーポレイテッド	認知機能を改善するための方法および組成物
AU2015208233B2 (en)	2014-01-21	2019-08-29	Janssen Pharmaceutica Nv	Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (me)	2014-01-21	2020-04-20	Janssen Pharmaceutica Nv	Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
CN103910649A (zh) *	2014-04-29	2014-07-09	苏州天马精细化学品股份有限公司	一种左乙拉西坦中间体（s）-n-[1-(氨基羰基)丙基]-4-氯代丁酰胺的合成方法
CN103922988A (zh) *	2014-04-29	2014-07-16	苏州天马精细化学品股份有限公司	一种左乙拉西坦粗品的纯化方法
CN104860863B (zh) *	2015-04-10	2017-06-20	惠州信立泰药业有限公司	左乙拉西坦和含其的药物组合物
AU2016268096B2 (en)	2015-05-22	2021-04-01	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
JP6902033B2 (ja)	2015-12-30	2021-07-14	アダマスファーマシューティカルズ，インコーポレイテッド	発作−関連障害の処置のための方法および組成物
CN106432032B (zh) *	2016-09-14	2019-07-12	苏州天马药业有限公司	一种左乙拉西坦的制备方法
CN106591179B (zh) *	2016-12-05	2018-07-03	长兴制药股份有限公司	甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用
TWI808952B (zh)	2016-12-16	2023-07-21	瑞士商愛杜西亞製藥有限公司	包含t型鈣通道阻斷劑之醫藥組合
CN108503610B (zh)	2017-02-24	2019-09-13	北京艾百诺医药股份有限公司	一种光学纯的(r)-4-正丙基-二氢呋喃-2(3h)-酮的制备方法
CN107337628B (zh) *	2017-08-10	2022-02-08	浙江华海药业股份有限公司	一种制备左乙拉西坦的方法
TWI826531B (zh)	2018-09-21	2023-12-21	南韓商愛思開生物製藥股份有限公司	具有㗁二唑之化合物及包含該化合物之醫藥組合物
CN110003074A (zh)	2019-04-23	2019-07-12	浙江华海药业股份有限公司	一种左乙拉西坦中间体的制备方法
TW202114655A (zh)	2019-08-14	2021-04-16	瑞士商辛鐵堤卡公司	左乙拉西坦(levetiracetam)之鞘內投藥
US11384050B1 (en) *	2021-02-03	2022-07-12	Vitaworks Ip, Llc	Method for preparing levetiracetam and intermediates thereof
JP2024508052A (ja)	2021-02-26	2024-02-21	シンデシセラピューティクスソシエテアノニム	認知障害の治療のための化合物
CN113979911A (zh) *	2021-11-12	2022-01-28	汤斌	一种从大鲵肽中提取乙拉西坦的方法
US20240368081A1 (en) *	2023-05-05	2024-11-07	Suzhou Brighthope Pharmatech Co., Ltd	Process for the production of levetiracetam and intermediate thereof
US20240368080A1 (en) *	2023-05-05	2024-11-07	Suzhou Brighthope Pharmatech Co., Ltd	Process for the production of levetiracetam and intermediate thereof
US20240368082A1 (en) *	2023-05-05	2024-11-07	Suzhou Brighthope Pharmatech Co., Ltd	Process for the production of levetiracetam and intermediate thereof
US20240409511A1 (en) *	2023-06-12	2024-12-12	Suzhou Brighthope Pharmatech Co., Ltd	Process for the production of levetiracetam and intermediates thereof
WO2025132331A1 (en)	2023-12-21	2025-06-26	UCB Biopharma SRL	Compounds for treatment of a hyperkinetic movement disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1309692A (en) *	1970-02-13	1973-03-14	Ucb Sa	N-substituted lactams
GB1583871A (en) *	1976-10-19	1981-02-04	Ucb Sa	Anti-aggregants
FR2418790A1 (fr) *	1978-03-02	1979-09-28	Philagro Sa	Nouveaux derives de pyrrolidinone-2 et compositions herbicides les contenant
GB8412358D0 (en) *	1984-05-15	1984-06-20	Ucb Sa	Pharmaceutical composition

1984
- 1984-05-15 GB GB848412357A patent/GB8412357D0/en active Pending
1985
- 1985-05-04 BG BG089449A patent/BG50156A3/xx unknown
- 1985-05-13 FI FI851875A patent/FI80673C/fi not_active IP Right Cessation
- 1985-05-13 GR GR851155A patent/GR851155B/el unknown
- 1985-05-13 IL IL75179A patent/IL75179A/xx not_active IP Right Cessation
- 1985-05-14 BG BG070238A patent/BG47497A3/xx unknown
- 1985-05-14 DE DE2000175021 patent/DE10075021I1/de active Pending
- 1985-05-14 EP EP85870069A patent/EP0162036B1/fr not_active Expired
- 1985-05-14 AT AT85870069T patent/ATE45567T1/de active
- 1985-05-14 CA CA000481512A patent/CA1235129A/en not_active Expired
- 1985-05-14 JP JP60102529A patent/JPH0629186B2/ja not_active Expired - Fee Related
- 1985-05-14 DE DE8585870069T patent/DE3572348D1/de not_active Expired
- 1985-05-14 UA UA3968802A patent/UA6158A1/uk unknown
- 1985-05-14 SU SU853898053A patent/SU1402260A3/ru active
- 1985-05-14 DE DE2001199005 patent/DE10199005I2/de active Active
- 1985-05-14 PT PT80460A patent/PT80460B/pt unknown
- 1985-05-14 DK DK212985A patent/DK163501C/da not_active IP Right Cessation
- 1985-05-14 PL PL1985257385A patent/PL147386B1/pl unknown
- 1985-05-14 PL PL1985253374A patent/PL144346B1/pl unknown
- 1985-05-14 NO NO851933A patent/NO164534C/no active Protection Beyond IP Right Term
- 1985-05-14 AU AU42530/85A patent/AU574465B2/en not_active Expired
- 1985-05-14 ES ES543124A patent/ES8608485A1/es not_active Expired
- 1985-05-14 IE IE119385A patent/IE59950B1/en not_active IP Right Cessation
- 1985-05-14 US US06/733,790 patent/US4696943A/en not_active Expired - Lifetime
- 1985-05-14 ES ES000551428A patent/ES8704893B9/es not_active Expired - Fee Related
- 1985-05-14 ZA ZA853635A patent/ZA853635B/xx unknown
- 1985-05-15 KR KR1019850003322A patent/KR920003819B1/ko not_active Expired
- 1985-07-10 CN CN85105301A patent/CN1015541B/zh not_active Expired
- 1985-10-25 SU SU853968802A patent/SU1430392A1/ru active
1986
- 1986-08-13 SU SU864027938A patent/SU1428195A3/ru active
1987
- 1987-03-12 US US07/025,277 patent/US4837223A/en not_active Expired - Lifetime
- 1987-04-20 MY MYPI87000506A patent/MY101725A/en unknown
- 1987-04-20 MY MYPI87000507A patent/MY101726A/en unknown
1989
- 1989-02-16 US US07/311,631 patent/US4943639A/en not_active Expired - Lifetime
1990
- 1990-10-02 SG SG800/90A patent/SG80090G/en unknown
1991
- 1991-07-11 HK HK523/91A patent/HK52391A/xx not_active IP Right Cessation
- 1991-12-20 CY CY1567A patent/CY1567A/xx unknown
1993
- 1993-05-19 LV LV930379A patent/LV5233A3/xx unknown
- 1993-08-17 LT LTRP873A patent/LT2584B/xx not_active IP Right Cessation
1999
- 1999-09-03 GE GEAP19994979A patent/GEP20002001B/en unknown
2000
- 2000-07-31 LU LU90615C patent/LU90615I2/fr unknown
- 2000-11-17 NL NL300028C patent/NL300028I2/nl unknown
- 2000-11-30 LU LU90682C patent/LU90682I2/fr unknown
2001
- 2001-01-20 SA SA01210656A patent/SA01210656A/ar unknown
- 2001-05-25 NO NO2001008C patent/NO2001008I2/no unknown
2004
- 2004-10-27 CY CY200400007C patent/CY2004007I1/el unknown

Also Published As

Publication number	Publication date
FI80673C (fi)	1990-07-10
CY1567A (en)	1991-12-20
GR851155B (xx)	1985-11-25
DK163501C (da)	1992-07-27
HK52391A (en)	1991-07-19
AU4253085A (en)	1986-11-20
FI80673B (fi)	1990-03-30
PL257385A1 (en)	1986-10-07
LT2584B (lt)	1994-03-25
DE10199005I1 (de)	2001-07-12
JPH0629186B2 (ja)	1994-04-20
US4696943A (en)	1987-09-29
NO2001008I2 (no)	2005-05-30
AU574465B2 (en)	1988-07-07
CN1015541B (zh)	1992-02-19
MY101726A (en)	1992-01-17
IE851193L (en)	1985-11-15
NO851933L (no)	1985-11-18
ATE45567T1 (de)	1989-09-15
ES8704893A1 (es)	1987-04-16
SG80090G (en)	1990-11-23
CY2004007I2 (el)	2009-11-04
ES543124A0 (es)	1986-06-16
FI851875L (fi)	1985-11-16
PT80460A (fr)	1985-06-01
NO164534C (no)	1990-10-17
GB8412357D0 (en)	1984-06-20
ES8608485A1 (es)	1986-06-16
DK212985A (da)	1985-11-16
DE10199005I2 (de)	2002-03-14
CN85105301A (zh)	1987-01-14
GEP20002001B (en)	2000-03-10
IL75179A (en)	1988-05-31
SU1402260A3 (ru)	1988-06-07
DE10075021I1 (de)	2000-10-19
DE3572348D1 (de)	1989-09-21
NL300028I1 (nl)	2001-02-01
LV5233A3 (lv)	1993-10-10
DK163501B (da)	1992-03-09
KR920003819B1 (ko)	1992-05-15
CA1235129A (en)	1988-04-12
PL147386B1 (en)	1989-05-31
EP0162036B1 (fr)	1989-08-16
NO164534B (no)	1990-07-09
PL144346B1 (en)	1988-05-31
NL300028I2 (nl)	2001-06-01
IL75179A0 (en)	1985-09-29
SA01210656A (ar)	2005-12-03
ES8704893B9 (es)	2012-02-07
LU90682I2 (fr)	2001-01-30
UA6158A1 (uk)	1994-12-29
FI851875A0 (fi)	1985-05-13
SU1428195A3 (ru)	1988-09-30
KR850008336A (ko)	1985-12-16
CY2004007I1 (el)	2009-11-04
PT80460B (pt)	1987-08-19
JPS60252461A (ja)	1985-12-13
BG50156A3 (en)	1992-05-15
US4837223A (en)	1989-06-06
PL253374A1 (en)	1986-05-06
MY101725A (en)	1992-01-17
EP0162036A1 (fr)	1985-11-21
US4943639A (en)	1990-07-24
LU90615I2 (fr)	2000-10-02
IE59950B1 (en)	1994-05-04
ZA853635B (en)	1985-12-24
SU1430392A1 (ru)	1988-10-15
DK212985D0 (da)	1985-05-14

Publication	Publication Date	Title
BG47497A3 (en)	1990-07-16	Method for preparing of (l)- alpha- ethyl- 2- oxo- 1- pyrolidineacetamide
BG43690A3 (en)	1988-07-15	Method for preparing of pyridazine amines
ES540638A0 (es)	1985-11-16	Un procedimiento de preparar 5,6,7,8-tetrahidro-6-(l-eritro-1',2'-dihidroxipropil)-pterina.
DE3680800D1 (de)	1991-09-19	Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin.
ATE48278T1 (de)	1989-12-15	Verfahren zur herstellung von 2'desoxyadenosinverbindungen.
UA7088A1 (uk)	1995-06-30	Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
FR2327216A1 (fr)	1977-05-06	Procede de preparation d'acide formique pur
FR2320278A1 (fr)	1977-03-04	Procede perfectionne pour la production d'alcools de guerbet au moyen de catalyseurs au plomb insolubles
FR2363608A1 (fr)	1978-03-31	Procede de preparation de colorants " bisazoiques "
RO92320B (ro)	1987-10-02	Procedeu pentru prepararea clorurii de carnitinnitril optic activ
FR2321842A1 (fr)	1977-03-25	Amides d'acides 3-pyridyl-oxy-alcane-carboxyliques, leur procede de preparation et leur application a la regulation de la croissance des plantes
BE841199A (fr)	1976-10-28	Procede de preparation de solutions d'acides percarboxyliques
BE849723A (fr)	1977-06-22	Nouveaux regulateurs de la croissance des plantes, a base d'anilides d'acides ammonium quaternaire-alcanoiques
ATE1997T1 (de)	1982-12-15	Verfahren zur gewinnung der enantiomeren formen von 4-cyan-1-(n-methyl-n-(2'-((3'',4''dimethoxyphenyl))-ethyl)-amino)-5-methyl-4(3',4',5'-trimethoxyphenyl)-hexan und dessen salzen.
FR2354339A1 (fr)	1978-01-06	Procede de preparation d'acides 1-aminoalcane-1,1-diphosphoniques
PT93991A (pt)	1991-02-08	Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
ES8507098A1 (es)	1985-09-16	Procedimiento para la preparacion de l(-)carnitina en forma de cloridrato o en forma de su sal interna.
FR2361341A1 (fr)	1978-03-10	Procede de preparation d'esters de l'acide anthranilique
IT8420610A1 (it)	1985-10-18	"Procedimento per migliorare la crescita delle piante mediante illuminazione intermittente"
ES547124A0 (es)	1986-04-01	Procedimiento para hidratar compuestos de nitrilo
FI894119A0 (fi)	1989-09-01	Menetelmä isoseriini-N,N-dietikkahapon trinatriumsuolan valmistamiseksi
PT85593A (en)	1987-09-01	Process for preparing substituted hexahydroarylquinolizines
ATE107631T1 (de)	1994-07-15	Verfahren zur herstellung von indolinon-2- derivaten.
HUT41375A (en)	1987-04-28	Process for producing cristalline glutaminic acid, first of all as monosodium salt, and process for producing salts and organic concentrate produced during the process
FR2446841A1 (fr)	1980-08-14	Procede de preparation de 1a,3b-dihydroxy-d5-steroides